HERCESSI 420 mg/20mL
Trastuzumab-strf · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Accord BioPharma Inc.
HERCESSI is a injection, powder, lyophilized, for solution containing trastuzumab-strf at 420 mg/20mL, taken intravenous. Manufactured by Accord BioPharma Inc..
Key Facts
- Brand Name
- HERCESSI
- Generic Name
- Trastuzumab-strf
- NDC Code (Product)
69448-016- Manufacturer
- Accord BioPharma Inc.
- Strength
- 420 mg/20mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761346
- Marketing Start
- 01/01/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is HERCESSI used for?
HERCESSI contains Trastuzumab-strf. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is HERCESSI a controlled substance?
HERCESSI is not classified as a controlled substance by the DEA.
What is the generic name for HERCESSI?
The generic name for HERCESSI is Trastuzumab-strf. There are no other listed brand versions of Trastuzumab-strf.
What is the NDC code for HERCESSI 420 mg/20mL?
The NDC (National Drug Code) for HERCESSI 420 mg/20mL is 69448-016, listed by Accord BioPharma Inc..
Other HERCESSI Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)